These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16566296)

  • 21. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
    Wang SX; Pandey KC; Scharfstein J; Whisstock J; Huang RK; Jacobelli J; Fletterick RJ; Rosenthal PJ; Abrahamson M; Brinen LS; Rossi A; Sali A; McKerrow JH
    Structure; 2007 May; 15(5):535-43. PubMed ID: 17502099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic or chemical protease inhibition causes significant changes in the Bacillus subtilis exoproteome.
    Westers L; Westers H; Zanen G; Antelmann H; Hecker M; Noone D; Devine KM; van Dijl JM; Quax WJ
    Proteomics; 2008 Jul; 8(13):2704-13. PubMed ID: 18546160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.
    Blum A; Böttcher J; Sammet B; Luksch T; Heine A; Klebe G; Diederich WE
    Bioorg Med Chem; 2008 Sep; 16(18):8574-86. PubMed ID: 18760609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of approaches to preventing and avoiding proteolysis during expression and purification of proteins.
    Ryan BJ; Henehan GT
    Curr Protoc Protein Sci; 2013 Feb; Chapter 5():Unit5.25. PubMed ID: 23377852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient degradation-aided selection of protease inhibitors by phage display.
    Hawinkels LJ; van Rossenberg SM; de Jonge-Muller ES; Molenaar TJ; Appeldoorn CC; van Berkel TJ; Sier CF; Biessen EA
    Biochem Biophys Res Commun; 2007 Dec; 364(3):549-55. PubMed ID: 17959143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.
    Zhou W; Scott SA; Shelton SB; Crutcher KA
    Neuroscience; 2006 Dec; 143(3):689-701. PubMed ID: 16997486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease.
    Hesek D; Toth M; Krchnak V; Fridman R; Mobashery S
    J Org Chem; 2006 Aug; 71(16):5848-54. PubMed ID: 16872162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of sulfamides as enzyme inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2006 Nov; 26(6):767-92. PubMed ID: 16710859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection-by-function: efficient enrichment of cathepsin E inhibitors from a DNA library.
    Naimuddin M; Kitamura K; Kinoshita Y; Honda-Takahashi Y; Murakami M; Ito M; Yamamoto K; Hanada K; Husimi Y; Nishigaki K
    J Mol Recognit; 2007; 20(1):58-68. PubMed ID: 17173335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 33. Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets.
    Bonturi CR; Silva Teixeira AB; Rocha VM; Valente PF; Oliveira JR; Filho CMB; Fátima Correia Batista I; Oliva MLV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
    Morrison CJ; Butler GS; Rodríguez D; Overall CM
    Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic plasticity-associated proteases and protease inhibitors in the brain linked to the processing of extracellular matrix and cell adhesion molecules.
    Lee TW; Tsang VW; Birch NP
    Neuron Glia Biol; 2008 Aug; 4(3):223-34. PubMed ID: 19674509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
    Flipo M; Beghyn T; Charton J; Leroux VA; Deprez BP; Deprez-Poulain RF
    Bioorg Med Chem; 2007 Jan; 15(1):63-76. PubMed ID: 17070058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of potent aspartic protease inhibitors to treat various diseases.
    Nguyen JT; Hamada Y; Kimura T; Kiso Y
    Arch Pharm (Weinheim); 2008 Sep; 341(9):523-35. PubMed ID: 18763714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When the surface tells what lies beneath: combinatorial phage-display mutagenesis reveals complex networks of surface-core interactions in the pacifastin protease inhibitor family.
    Szenthe B; Patthy A; Gáspári Z; Kékesi AK; Gráf L; Pál G
    J Mol Biol; 2007 Jun; 370(1):63-79. PubMed ID: 17499271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of proteinase inhibitors on efficiency of suppression of proteolytic activation in pneumonia].
    Kubyshkin AV; Fomochkina II
    Fiziol Zh (1994); 2009; 55(1):43-8. PubMed ID: 19441714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
    Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ
    Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.